Terms: = Cervical cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Treatment
29 results:
1. Exploration of the Mechanism of Kaempferol in the treatment of cervical cancer-based on Metabolomics and Network Pharmacology.
Cao DM; Liu T
Curr Pharm Des; 2023; 29(36):2877-2890. PubMed ID: 38062663
[TBL] [Abstract] [Full Text] [Related]
2. Alkaloids from
Wan Q; Xu J; Zhu C; Liu X; Tu Y; Lei J; Yu J
J Agric Food Chem; 2023 Jul; 71(27):10349-10360. PubMed ID: 37392181
[No Abstract] [Full Text] [Related]
3. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
[TBL] [Abstract] [Full Text] [Related]
4. Combination treatment of Retinoic Acid Plus Focal Adhesion Kinase Inhibitor Prevents Tumor Growth and Breast cancer Cell Metastasis.
Castro-Guijarro AC; Vanderhoeven F; Mondaca JM; Redondo AL; Zoppino FCM; Fernandez-Muñoz JM; Sanchez AM; Flamini MI
Cells; 2022 Sep; 11(19):. PubMed ID: 36230951
[TBL] [Abstract] [Full Text] [Related]
5. Redox Regulation of NOX Isoforms on FAK
Kim YM; Muthuramalingam K; Cho M
Cells; 2020 Jun; 9(6):. PubMed ID: 32604782
[TBL] [Abstract] [Full Text] [Related]
6. Bosutinib Acts as a Tumor Inhibitor via Downregulating src/NF-κB/Survivin Expression in HeLa Cells.
Yu L; Guo W; Liu L; Zhang G; Zhang F; Qu Y; Liu Y; Li H; Li H
Anat Rec (Hoboken); 2019 Dec; 302(12):2193-2200. PubMed ID: 31569304
[TBL] [Abstract] [Full Text] [Related]
7. Shp2 expression is upregulated in cervical cancer, and Shp2 contributes to cell growth and migration and reduces sensitivity to cisplatin in cervical cancer cells.
Cao M; Gao D; Zhang N; Duan Y; Wang Y; Mujtaba H; Wang Y
Pathol Res Pract; 2019 Nov; 215(11):152621. PubMed ID: 31564571
[TBL] [Abstract] [Full Text] [Related]
8. Identification of Candidate Plasma Protein Biomarkers for cervical cancer Using the Multiplex Proximity Extension Assay.
Berggrund M; Enroth S; Lundberg M; Assarsson E; Stålberg K; Lindquist D; Hallmans G; Grankvist K; Olovsson M; Gyllensten U
Mol Cell Proteomics; 2019 Apr; 18(4):735-743. PubMed ID: 30692274
[TBL] [Abstract] [Full Text] [Related]
9. Vascular endothelial growth factor C promotes cervical cancer cell invasiveness via regulation of microRNA-326/cortactin expression.
Cheng Y; Jiang S; Yuan J; Liu J; Simoncini T
Gynecol Endocrinol; 2018 Oct; 34(10):853-858. PubMed ID: 29658350
[TBL] [Abstract] [Full Text] [Related]
10. Involvement of src signaling in the synergistic effect between cisplatin and digoxin on cancer cell viability.
Pereira DG; Salgado MAR; Rocha SC; Santos HL; Villar JAFP; Contreras RG; Fontes CFL; Barbosa LA; Cortes VF
J Cell Biochem; 2018 Apr; 119(4):3352-3362. PubMed ID: 29130514
[TBL] [Abstract] [Full Text] [Related]
11. Amorfrutin A inhibits TNF-α induced JAK/STAT signaling, cell survival and proliferation of human cancer cells.
Mi C; Ma J; Wang KS; Wang Z; Li MY; Li JB; Li X; Piao LX; Xu GH; Jin X
Immunopharmacol Immunotoxicol; 2017 Dec; 39(6):338-347. PubMed ID: 28879797
[TBL] [Abstract] [Full Text] [Related]
12. Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.
Musa J; Achenbach CJ; O'Dwyer LC; Evans CT; McHugh M; Hou L; Simon MA; Murphy RL; Jordan N
PLoS One; 2017; 12(9):e0183924. PubMed ID: 28873092
[TBL] [Abstract] [Full Text] [Related]
13. Gamma tocotrienol targets tyrosine phosphatase SHP2 in mammospheres resulting in cell death through RAS/ERK pathway.
Gu W; Prasadam I; Yu M; Zhang F; Ling P; Xiao Y; Yu C
BMC Cancer; 2015 Aug; 15():609. PubMed ID: 26315028
[TBL] [Abstract] [Full Text] [Related]
14. Improved chemosensitivity in cervical cancer to cisplatin: synergistic activity of mahanine through STAT3 inhibition.
Das R; Bhattacharya K; Samanta SK; Pal BC; Mandal C
Cancer Lett; 2014 Aug; 351(1):81-90. PubMed ID: 24831030
[TBL] [Abstract] [Full Text] [Related]
15. Role of serum VEGFA, TIMP2, MMP2 and MMP9 in monitoring response to adjuvant radiochemotherapy in patients with primary cervical cancer--results of a companion protocol of the randomized NOGGO-AGO phase III clinical trial.
Braicu EI; Gasimli K; Richter R; Nassir M; Kümmel S; Blohmer JU; Yalcinkaya I; Chekerov R; Ignat I; Ionescu A; Mentze M; Fotopoulou C; Pop C; Lichtenegger W; Sehouli J; ;
Anticancer Res; 2014 Jan; 34(1):385-91. PubMed ID: 24403492
[TBL] [Abstract] [Full Text] [Related]
16. SHP-2 phosphatase promotes cervical cancer cell proliferation through inhibiting interferon-β production.
Meng F; Zhao X; Zhang S
J Obstet Gynaecol Res; 2013 Jan; 39(1):272-9. PubMed ID: 22889324
[TBL] [Abstract] [Full Text] [Related]
17. Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma.
Zhou J; Roh JW; Bandyopadhyay S; Chen Z; Munkarah AR; Hussein Y; Alosh B; Jazaerly T; Hayek K; Semaan A; Sood AK; Ali-Fehmi R
Gynecol Oncol; 2013 Feb; 128(2):344-8. PubMed ID: 22871469
[TBL] [Abstract] [Full Text] [Related]
18. A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study.
Sehouli J; Runnebaum IB; Fotopoulou C; Blohmer U; Belau A; Leber H; Hanker LC; Hartmann W; Richter R; Keyver-Paik MD; Oberhoff C; Heinrich G; du Bois A; Olbrich C; Simon E; Friese K; Kimmig R; Boehmer D; Lichtenegger W; Kuemmel S
Ann Oncol; 2012 Sep; 23(9):2259-2264. PubMed ID: 22357252
[TBL] [Abstract] [Full Text] [Related]
19. src inhibitors are promising therapy molecules for human cervical carcinomas.
Al Moustafa AE; Yasmeen A; Alachkar A
Med Hypotheses; 2011 Nov; 77(5):812-4. PubMed ID: 21864985
[TBL] [Abstract] [Full Text] [Related]
20. [c-src knockdown decreases phosphorylated STAT3 expression and viability of HeLa cells].
Chen JX; Xu LL; Wu SJ; Liu HY; Wang JL; Zou T
Sheng Li Xue Bao; 2011 Jun; 63(3):198-204. PubMed ID: 21681336
[TBL] [Abstract] [Full Text] [Related]
[Next]
